HB5373 Summary

• Adds Section 315.7 to the Illinois Controlled Substances Act establishing that chronic pain treatment decisions must be made by prescribers and dispensed by pharmacists in accordance with federal regulations and state rules.

• Defines chronic pain as pain persisting more than 12 weeks that adversely affects function or well-being, and opioids as Schedule II controlled substances.

• Prohibits predetermined limits on ordering, prescribing, dispensing, or paying for controlled substances based on morphine milligram equivalent guidelines except as required by federal law.

• Requires the Prescription Monitoring Program's Peer Review Committee to review updated clinical guidelines on chronic pain treatment when evaluating prescriptions for chronic pain patients.

• Amends Section 318 regarding Prescription Monitoring Program confidentiality, requiring court orders or administrative subpoenas for information release and clarifying protections for confidential substance use disorder patient records under federal regulations.